Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom
Thermo Fisher shares closed up 2.4% at $621.83 Wednesday and held steady after hours, following news of new U.S. drug manufacturing contracts. CEO Marc Casper cited a focus on reshoring production from Europe and Asia. A recent SEC filing detailed leadership changes effective in March, including COO Michel Lagarde’s exit. The company also announced a partnership with Nvidia to expand AI in lab automation.